title: Effectiveness of a complex intervention in reducing the prevalence of smoking among adolescents: study design of a cluster-randomized controlled trial.
abstract: BACKGROUND
  The likelihood of an adolescent taking up smoking may be influenced by his or her society, school and family. Thus, changes in the immediate environment may alter a young person's perception of smoking.
  
  
  METHODS
  The proposed multi-center, cluster-randomized controlled trial will be stratified by the baseline prevalence of smoking in schools. Municipalities with fewer than 100,000 inhabitants will be randomly assigned to a control or intervention group. One secondary school will be randomly selected from each municipality. These schools will be randomized to two groups: the students of one will receive any existing educational course regarding smoking, while those of the other school will receive a four-year, class-based curriculum intervention (22 classroom lessons) aimed at reinforcing a smoke-free school policy and encouraging smoking cessation in parents, pupils, and teachers. The intervention will also include annual meetings with parents and efforts to empower adolescents to change the smoking-related attitudes and behaviors in their homes, classrooms and communities.We will enroll children aged 12-13 years as they enter secondary school during two consecutive school years (to obtain sufficient enrolled subjects). We will follow them for five years, until two years after they leave secondary school. All external evaluators and analysts will be blinded to school allocation.The aim of this study is to analyze the effectiveness of a complex intervention in reducing the prevalence of smoking in the third year of compulsory secondary education (ESO) and two years after secondary school, when the participants are 14-15 and 17-18 years old, respectively.
  
  
  CONCLUSIONS
  Most interventions aimed at preventing smoking among adolescents yield little to no positive long-term effects. This clinical trial will analyze the effectiveness of a complex intervention aimed at reducing the incidence and prevalence of smoking in this vulnerable age group.
  
  
  BACKGROUND
  Current Controlled Trials: NCT01602796.
authors.affiliation: Primary Care Research Unit of Mallorca, Baleares Health services-IbSalut, Mallorca, Spain. aleiva@ibsalut.caib.es.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Leiva
authors.forename: Andreu
authors.initials: A
authors.lastname: Estela
authors.forename: Maties
authors.initials: M
authors.lastname: Torrent
authors.forename: Amador
authors.initials: A
authors.lastname: Calafat
authors.forename: Miquel
authors.initials: M
authors.lastname: Bennasar
authors.forename: Aina
authors.initials: A
authors.lastname: Yáñez
mesh_terms: D000293:Adolescent; D002648:Child; D003479:Curriculum; D005260:Female; D006293:Health Promotion / Q000379:methods; D006801:Humans; D008297:Male; D010290:Parents; D015995:Prevalence; D012107:Research Design; D012574:Schools; D061845:Smoke-Free Policy; D012907:Smoking / Q000453:epidemiology; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013334:Students
references.citation: Med J Aust. 1990 Feb 5;152(3):117-24
references.pmid: 2405239
references.citation: Br Med Bull. 1996 Jan;52(1):12-21
references.pmid: 8746293
references.citation: Soc Sci Med. 2004 Jun;58(11):2253-65
references.pmid: 15047082
references.citation: Gac Sanit. 2002 Mar-Apr;16(2):131-8
references.pmid: 11958749
references.citation: Health Educ Res. 2002 Dec;17(6):750-60
references.pmid: 12507350
references.citation: Scand J Public Health. 2009 Mar;37(2):146-52
references.pmid: 19141546
references.citation: J Health Soc Behav. 2003 Dec;44(4):525-35
references.pmid: 15038147
references.citation: Rev Esp Salud Publica. 2002 May-Jun;76(3):227-38
references.pmid: 12092469
references.citation: Am J Public Health. 1992 Sep;82(9):1210-6
references.pmid: 1503159
references.citation: Am J Epidemiol. 1996 Aug 15;144(4):425-33
references.pmid: 8712201
references.citation: Addict Behav. 1999 Sep-Oct;24(5):673-7
references.pmid: 10574304
references.citation: BMJ. 1999 Oct 9;319(7215):948-53
references.pmid: 10514156
references.citation: Prev Med. 2002 Nov;35(5):506-10
references.pmid: 12431899
references.citation: Adicciones. 2013;25(3):253-9
references.pmid: 23880838
references.citation: Am J Public Health. 1998 Jan;88(1):81-5
references.pmid: 9584038
references.citation: Bull World Health Organ. 1999;77(6):509-14
references.pmid: 10427936
references.citation: J Natl Cancer Inst. 2000 Dec 20;92(24):1979-91
references.pmid: 11121460
references.citation: Arch Bronconeumol. 2006 Jan;42(1):21-4
references.pmid: 16426519
references.citation: BMC Public Health. 2006 Nov 10;6:280
references.pmid: 17096837
references.citation: Prev Med. 2007 Aug-Sep;45(2-3):189-97
references.pmid: 17433427
references.citation: Arch Bronconeumol. 2004 Nov;40(11):495-501
references.pmid: 15530341
references.citation: Med Clin (Barc). 1997 Mar 1;108(8):293-8
references.pmid: 9121205
references.citation: Tob Control. 2008 Oct;17(5):301-2
references.pmid: 18522963
references.citation: BMJ. 2000 Aug 5;321(7257):333-7
references.pmid: 10926588
references.citation: Nicotine Tob Res. 1999;1 Suppl 2:S111-4; discussion 569-70
references.pmid: 11768166